etidronate and fluorodeoxyglucose f18

etidronate has been researched along with fluorodeoxyglucose f18 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khuri, F; Saba, N1
Choi, SJ; Ji, JD; Kim, S; Lee, YH; Song, GG; Woo, JH1
Blake, GM; Eastell, R; Fogelman, I; Frost, ML; Marsden, PK; Moore, AE; Schleyer, PJ; Siddique, M1

Reviews

1 review(s) available for etidronate and fluorodeoxyglucose f18

ArticleYear
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
    Oncology, 2005, Volume: 68, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Clodronic Acid; Diphosphonates; Etidronic Acid; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Ibandronic Acid; Imidazoles; Lung Neoplasms; Pamidronate; Positron-Emission Tomography; Predictive Value of Tests; Therapeutic Equivalency; Zoledronic Acid

2005

Trials

1 trial(s) available for etidronate and fluorodeoxyglucose f18

ArticleYear
Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:8

    Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Etidronic Acid; Female; Femur; Fluorodeoxyglucose F18; Hip; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Positron-Emission Tomography; Radiopharmaceuticals; Risedronic Acid; Treatment Outcome

2012

Other Studies

1 other study(ies) available for etidronate and fluorodeoxyglucose f18

ArticleYear
Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT.
    International journal of rheumatic diseases, 2010, Volume: 13, Issue:4

    Topics: Asymptomatic Diseases; Bone Density Conservation Agents; Diagnosis, Differential; Etidronic Acid; Female; Fluorodeoxyglucose F18; Humans; Ilium; Incidental Findings; Middle Aged; Osteitis Deformans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risedronic Acid; Sclerosis; Tomography, X-Ray Computed; Whole Body Imaging

2010